233 related articles for article (PubMed ID: 12403340)
1. Complement in central nervous system inflammation.
Barnum SR
Immunol Res; 2002; 26(1-3):7-13. PubMed ID: 12403340
[TBL] [Abstract][Full Text] [Related]
2. Complement anaphylatoxin receptors on neurons: new tricks for old receptors?
Nataf S; Stahel PF; Davoust N; Barnum SR
Trends Neurosci; 1999 Sep; 22(9):397-402. PubMed ID: 10441300
[TBL] [Abstract][Full Text] [Related]
3. Complement c3a and c5a induce different signal transduction cascades in endothelial cells.
Schraufstatter IU; Trieu K; Sikora L; Sriramarao P; DiScipio R
J Immunol; 2002 Aug; 169(4):2102-10. PubMed ID: 12165538
[TBL] [Abstract][Full Text] [Related]
4. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann M; Götze O
Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
[TBL] [Abstract][Full Text] [Related]
5. The proinflammatory mediators C3a and C5a are essential for liver regeneration.
Strey CW; Markiewski M; Mastellos D; Tudoran R; Spruce LA; Greenbaum LE; Lambris JD
J Exp Med; 2003 Sep; 198(6):913-23. PubMed ID: 12975457
[TBL] [Abstract][Full Text] [Related]
6. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
[TBL] [Abstract][Full Text] [Related]
7. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.
Peng Q; Li K; Sacks SH; Zhou W
Inflamm Allergy Drug Targets; 2009 Jul; 8(3):236-46. PubMed ID: 19601884
[TBL] [Abstract][Full Text] [Related]
8. Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitis.
Ramos TN; Wohler JE; Barnum SR
Neurosci Lett; 2009 Dec; 467(3):234-6. PubMed ID: 19850104
[TBL] [Abstract][Full Text] [Related]
9. The intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury.
Sakuma M; Morooka T; Wang Y; Shi C; Croce K; Gao H; Strainic M; Medof ME; Simon DI
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1196-202. PubMed ID: 20299685
[TBL] [Abstract][Full Text] [Related]
10. IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production.
Liu J; Lin F; Strainic MG; An F; Miller RH; Altuntas CZ; Heeger PS; Tuohy VK; Medof ME
J Immunol; 2008 May; 180(9):5882-9. PubMed ID: 18424707
[TBL] [Abstract][Full Text] [Related]
11. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
[TBL] [Abstract][Full Text] [Related]
12. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.
Engelke C; Wiese AV; Schmudde I; Ender F; Ströver HA; Vollbrandt T; König P; Laumonnier Y; Köhl J
J Immunol; 2014 Dec; 193(11):5387-401. PubMed ID: 25355927
[TBL] [Abstract][Full Text] [Related]
14. CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model.
Ingersoll SA; Martin CB; Barnum SR; Martin BK
Mol Immunol; 2010; 48(1-3):219-30. PubMed ID: 20813409
[TBL] [Abstract][Full Text] [Related]
15. Human T cells express the C5a receptor and are chemoattracted to C5a.
Nataf S; Davoust N; Ames RS; Barnum SR
J Immunol; 1999 Apr; 162(7):4018-23. PubMed ID: 10201923
[TBL] [Abstract][Full Text] [Related]
16. Complement: a novel factor in basal and ischemia-induced neurogenesis.
Rahpeymai Y; Hietala MA; Wilhelmsson U; Fotheringham A; Davies I; Nilsson AK; Zwirner J; Wetsel RA; Gerard C; Pekny M; Pekna M
EMBO J; 2006 Mar; 25(6):1364-74. PubMed ID: 16498410
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
[TBL] [Abstract][Full Text] [Related]
18. Neuronal expression of a functional receptor for the C5a complement activation fragment.
O'Barr SA; Caguioa J; Gruol D; Perkins G; Ember JA; Hugli T; Cooper NR
J Immunol; 2001 Mar; 166(6):4154-62. PubMed ID: 11238666
[TBL] [Abstract][Full Text] [Related]
19. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
[TBL] [Abstract][Full Text] [Related]
20. New concepts on the therapeutic control of complement anaphylatoxin receptors.
Hawksworth OA; Li XX; Coulthard LG; Wolvetang EJ; Woodruff TM
Mol Immunol; 2017 Sep; 89():36-43. PubMed ID: 28576324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
